Aligos TherapeuticsALGS
13F holders, Q1 2025 (March 31)35holders +2
11new positions
8sold out
1famous investor
$8.22avg. 13F price*
At the end of Q1 2025, 35 institutions reported holding Aligos Therapeutics Inc. (ALGS) in their 13F filings, up 2 from Q4 2024. 11 opened new positions and 8 sold out. The largest holders were Adage Capital Partners Gp, L.L.C. ($3.8M), Deep Track Capital, LP ($3.7M) and Alyeska Investment Group, L.P. ($3.4M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Aligos Therapeutics Inc.
- CUSIP
- 01626L204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $13.6M |
| Exits | 8 | $7.6M |
All 13F filers, Q4 2024 → Q1 2025: 2,229,491 shares bought and 551,982 shares sold, net +1,677,509 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Adage Capital Partners Gp, L.L.C. | 0.01% | Add +43.1% | 465,000 | $3.8M |
| Deep Track Capital, LP | 0.12% | Add +81.9% | 444,110 | $3.7M |
| Alyeska Investment Group, L.P. | 0.01% | New | 412,000 | $3.4M |
| Woodline Partners LP | 0.02% | New | 315,383 | $2.6M |
| Heights Capital Management, Inc. | 1.02% | New | 241,500 | $2.0M |
| Hudson Bay Capital Management LP | 0.01% | New | 241,500 | $1.9M |
| Sio Capital Management, LLC | 0.45% | New | 180,720 | $1.5M |
| Bank of America Corp. | 0.00% | Add +54111.6% | 154,503 | $1.3M |
| Tang Capital Management LLC | 0.06% | New | 141,131 | $1.2M |
| Vanguard Group Inc. | 0.00% | Add +45.5% | 140,749 | $1.2M |
| EcoR1 Capital, LLC | 0.04% | Reduce -65.3% | 88,569 | $731K |
| Baker Bros. Advisors LP | 0.01% | No change | 83,055 | $685K |
| HHLR Advisors, LTD. | 0.02% | No change | 76,247 | $629K |
| Readystate Asset Management LP | 0.03% | New | 45,400 | $375K |
| Susquehanna International Group, LLP | 0.00% | New | 40,612 | $335K |
| Renaissance Technologies | 0.00% | Add +245.8% | 39,576 | $327K |
| Trexquant Investment LP | 0.00% | Reduce -44.6% | 38,254 | $316K |
| Geode Capital Management, LLC | 0.00% | Add +3.0% | 28,070 | $232K |
| Wells Fargo & Company | 0.00% | Add +5.6% | 23,030 | $190K |
| AlphaQuest LLC | 0.01% | New | 15,760 | $130K |
| BlackRock, Inc. | 0.00% | Reduce -5.0% | 13,040 | $108K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -11.2% | 12,686 | $105K |
| Dimensional Fund Advisors LP | 0.00% | New | 11,216 | $93K |
| Two Sigma Investments, LP | 0.00% | New | 11,050 | $91K |
| Vivo Capital, LLC | 0.01% | Reduce -92.8% | 10,199 | $84K |
| UBS Group AG | 0.00% | Reduce -45.5% | 8,461 | $70K |
| Morgan Stanley | 0.00% | Add +131.9% | 7,498 | $62K |
| Golden State Wealth Management, LLC | 0.00% | No change | 2,674 | $22K |
| Royal Bank of Canada | 0.00% | Reduce -90.8% | 2,125 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +87.3% | 1,221 | $10K |
| Osaic Holdings, Inc. | 0.00% | Reduce -75.4% | 220 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 26 | $215 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -90.6% | 16 | $132 |
| Elevation Wealth Partners, LLC | 0.00% | No change | 4 | $33 |
| BNP Paribas Financial Markets | 0.00% | No change | 3 | $25 |
"% of holder's portfolio" is ALGS's weight in each manager's 13F, not the share of Aligos Therapeutics Inc. the manager owns.